3-Three Year BAROS Score Outcomes for One anastomosis Gastric Bypass and FundoRing One anastomosis Gastric Bypass

Oral Ospanov 1, Galymjan Duysenov 2 * , Venera Rakhmetova 3, Zhanbolat Dildabekov 4, Bakhtiyar Yelembayev 5
More Detail
1 Research and Education Center for Surgery named after Professor Tsoi G. V., Astana medical university, Astana, Kazakhstan
2 Surgery Center of Professor Oral Ospanov, Astana, Kazakhstan
3 Departments of Internal Medicine with Courses in Nephrology, Hematology, Allergology, and Immunology, Astana medical university, Astana, Kazakhstan
4 Public Association “Society of Bariatric and Metabolic Surgeons of Kazakhstan”, Astana, Kazakhstan
5 Public Association “Kazakhstan Society of Bariatric and Metabolic Surgeons”, Astana, Kazakhstan
* Corresponding Author
J CLIN MED KAZ, Volume 23, Issue 3, pp. 4-10. https://doi.org/10.23950/jcmk/18692
OPEN ACCESS 423 Views 138 Downloads
Download Full Text (PDF)
Author Contributions: Conceptualization, O. O.; investigation, G. D.; verification, V. R., B. Y., Zh. D.; writing – original draft preparation, G. D., B. Y., Zh. D.; writing – review and editing, O. O., G. D. The authors have read and agreed to the published version of the manuscript.

Data availability statement: All raw data underlying the findings of this study can be obtained from the corresponding author upon reasonable request.

Artificial Intelligence (AI) Disclosure Statement: Artificial intelligence was used to translate and edit the text to improve its readability in English, ensure efficient work under human supervision.

ABSTRACT

Objective: To compare the 3-year quality of life, weight loss, comorbidity remission, and complication rates between FundoRing One-Anastomosis Gastric Bypass (f-OAGB) and standard OAGB (s-OAGB) in patients with obesity.
Background: While OAGB is an effective metabolic procedure, it is associated with specific complications like bile reflux and marginal ulcers. The FundoRing modification, involving total fundoplication of the excluded stomach, may mitigate these risks. Long-term, patient-centered outcomes measured by the Bariatric Analysis and Reporting Outcome System (BAROS) are crucial.
Methods: In this single-center, prospective randomized trial, 1000 patients (BMI 30-50 kg/m²) were assigned 1:1 to f-OAGB (n=500) or s-OAGB (n=500) between January 2021 and December 2024. A detailed CONSORT flow diagram guided the study. Randomization was performed by a statistician using sequentially numbered opaque envelopes. Outcome assessors were blinded. The primary outcome was the total BAROS score at 3 years. Safety was assessed using structured criteria, including 30-day and late complications (Clavien-Dindo classification).
Results: At 3 years, follow-up was 83.0% (415/500) for f-OAGB and 87.0% (435/500) for s-OAGB (reasons for attrition: lost to follow-up, protocol violations, withdrawal of consent). The f-OAGB group demonstrated a significantly higher total BAROS score (5.59±1.13 vs. 4.57±1.09; mean difference 1.02, 95% CI 0.87–1.17; p<0.001), indicating a "very good" vs. "good" outcome. f-OAGB resulted in superior %EWL (84.3±12.1% vs. 76.8±14.3%; p<0.001), greater improvement in medical conditions, and better quality of life. No intraoperative, 30-day, or late mortality occurred in either group during the 3-year follow-up period (overall mortality 0%). f-OAGB was associated with significantly lower rates of bile reflux (0.2% vs. 9.4% at 3 years, p<0.001), marginal ulcers (0.2% vs. 3.4% at 3 years, p<0.001), and dumping syndrome (13.7% vs. 36.5% at 3 years, p<0.001).
Conclusions: At 3 years post-surgery, FundoRing OAGB is superior to standard OAGB in achieving better overall health outcomes as measured by the BAROS score. It provides enhanced weight loss, greater comorbidity resolution, and superior quality of life, while significantly reducing the risk of bile reflux, marginal ulceration, and dumping syndrome. F-OAGB represents a safe and effective technical advancement in metabolic surgery.
Keywords: OAGB, FundoRing, BAROS, Quality of Life, Metabolic Surgery

CITATION

Ospanov O, Duysenov G, Rakhmetova V, Dildabekov Z, Yelembayev B. 3-Three Year BAROS Score Outcomes for One anastomosis Gastric Bypass and FundoRing One anastomosis Gastric Bypass. J CLIN MED KAZ. 2026;23(3):4-10. https://doi.org/10.23950/jcmk/18692

REFERENCES

  • Zhou XD, Chen QF, Yang W, Zuluaga M, Targher G, Byrne CD, Valenti L, Luo F, Katsouras CS, Thaher O, Misra A, Ataya K, Oviedo RJ, Pik-Shan Kong A, Alswat K, Lonardo A, Wong YJ, Abu-Abeid A, Al Momani H, Ali A, Molina GA, Szepietowski O, Jumaev NA, Kızılkaya MC, Viveiros O, Toro-Huamanchumo CJ, Yen Kok KY, Ospanov O, Abbas SI, Robertson AG, Fouad Y, Mantzoros CS, Zhang H, Méndez-Sánchez N, Sookoian S, Chan WK, Treeprasertsuk S, Adams L, Ocama P, Ryan JD, Perera N, Sharara AI, Al-Busafi SA, Opio CK, Garcia M, Lim-Loo MC, Ruiz-Úcar E, Prasad A, Casajoana A, Abdelbaki TN, Zheng MH. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021. EClinicalMedicine. 2024; 76: 102848. https://doi.org/10.1016/j.eclinm.2024.102848. Erratum in: EClinicalMedicine. 2024; 78: 102958. https://doi.org/10.1016/j.eclinm.2024.102958.
  • Noel P, Cazeres C, Lutfi RE, Nocca D. A Comprehensive Review of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass, One-Anastomosis Gastric Bypass, Duodenal Switch, and SADI-S: Very Long-Term Outcomes at 10 Years and Beyond. J Laparoendosc Adv Surg Tech A. 2026: 10926429261419379. https://doi.org/10.1177/10926429261419379.
  • Gulinac M, Miteva DG, Peshevska-Sekulovska M, Novakov IP, Antovic S, Peruhova M, Snegarova V, Kabakchieva P, Assyov Y, Vasilev G, Sekulovski M, Lazova S, Tomov L, Velikova T. Long-term effectiveness, outcomes and complications of bariatric surgery. World J Clin Cases. 2023; 11(19): 4504-4512. https://doi.org/10.12998/wjcc.v11.i19.4504.
  • Kermansaravi M, Cohen RV, Shikora SA, Chiappetta S, Parmar C, Mahawar K, Aminian A, Dillemans B, Monami M, Belluzzi A, Nimeri A, Angrisani L, Di Lorenzo N, Prager G, Petry TB, Kassir R, De Luca M. Same-day Discharge Metabolic and Bariatric Surgery: a GRADE-based International Federation for the Surgery and Other Therapies for Obesity (IFSO) Position Statement. Obes Surg. 2026. https://doi.org/10.1007/s11695-026-08555-y.
  • Maselli DB, Hoff AC, Kucera A, Waseem A, Wooley C, Donnangelo LL, Coan B, McGowan CE. Endoscopic revision of one-anastomosis gastric bypass (ER-OAGB) for weight recurrence: a case series of 17 adults. Ther Adv Gastrointest Endosc. 2023; 16: 26317745231210120. https://doi.org/10.1177/26317745231210120.
  • Ospanov O, Zharov N, Yelembayev B, Duysenov G, Volchkova I, Sultanov K, Mustafin A. A Three-Arm Randomized Controlled Trial of Primary One-Anastomosis Gastric Bypass: With FundoRing or Nissen Fundoplications vs. without Fundoplication for the Treatment of Obesity and Gastroesophageal Reflux Disease. Medicina (Kaunas). 2024; 60(3): 405. https://doi.org/10.3390/medicina60030405.
  • Ospanov O. The Surgical Technique of Primary Modified Fundoplication Using the Excluded Stomach with Simultaneous Gastric Bypass. Obes Surg. 2023; 33(4): 1311-1313. https://doi.org/10.1007/s11695-023-06505-6.
  • Oria HE, Moorehead MK. Updated bariatric analysis and reporting outcome system (BAROS). Surg Obes Relat Dis. 2009; 5(1): 60-66.
  • Madani S, Shahsavan M, Pazouki A, Setarehdan SA, Yarigholi F, Eghbali F, Shahmiri SS, Kermansaravi M. Five-Year BAROS Score Outcomes for Roux-en-Y Gastric Bypass, One Anastomosis Gastric Bypass, and Sleeve Gastrectomy: a Comparative Study. Obes Surg. 2024; 34(2): 487-493. https://doi.org/10.1007/s11695-023-07015-1.
  • . Carbajo MA, Luque-de-León E, Jiménez JM, Ortiz-de-Solórzano J, Pérez-Miranda M, Castro-Alija MJ. Laparoscopic One-Anastomosis Gastric Bypass: Technique, Results, and Long-Term Follow-Up in 1200 Patients. Obes Surg. 2017; 27: 1153–1167. https://doi.org/10.1007/s11695-016-2428-1.
  • Ospanov O. Standardization of surgical technique of the fundoring method for laparoscopic gastric bypass. Sci Rep. 2025; 15(1): 44941. https://doi.org/10.1038/s41598-025-29153-5.
  • Marchetti M, Pan TL, Delfrati S, Gill S, Yates E, Meschini T, Vilches JC, Santía MC, Ramirez PT, Nelson G. Enhanced Recovery After Surgery (ERAS) in gynecologic surgery: hot topic debates at the 2025 ERAS World Congress. Int J Gynecol Cancer. 2026; 36(4): 104552. https://doi.org/10.1016/j.ijgc.2026.104552.
  • Ospanov O, Yelembayev B, Buchwald JN, Sultanov K, Rakhmetov M, Duysenov G, Tuleuov B. Comparative endoscopic ultrasound assessment of the gastric pouch after FundoRing-OAGB and OAGB. BMC Surg. 2025; 26(1): 23. https://doi.org/10.1186/s12893-025-03386-7.